Unsere Publikationen

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis

Link
https://doi.org/10.1001/jamaneurol.2024.0017
Tags
Multiple Sklerose
Jahr
2024
Autoren
Cross AH, Gelfand JM, Thebault S, Bennett JL, von Büdingen HC, Cameron B, Carruthers R, Edwards K, Fallis R, Gerstein R, Giacomini PS, Greenberg B, Hafler DA, Ionete C, Kaunzner UW, Kodama L, Lock C, Longbrake EE, Musch B, Pardo G, Piehl F, Weber MS, Yuen S, Ziemssen T, Bose G, Freedman MS, Anania VG, Ramesh A, Winger RC, Jia X, Herman A, Harp C, Bar-Or A.
Verlag
JAMA Neurol. 2024 Mar 11:e240017.
Zum Eintrag

Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort

Link
https://doi.org/10.3390/vaccines12030265
Tags
Multiple SkleroseNeuroimmunologieAndere
Jahr
2024
Autoren
Inojosa H, Schriefer D, Atta Y, Dillenseger A, Proschmann U, Schleußner K, Woopen C, Ziemssen T, Akgün K.
Verlag
Vaccines. 2024; 12(3):265.
Zum Eintrag

Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple Sclerosis

Link
https://doi.org/10.2147/PPA.S452849
Tags
Multiple SkleroseMS BehandlungManagement & ScienceeHealth
Jahr
2024
Autoren
Hoffmann O, Paul F, Haase R, Kern R, Ziemssen T.
Verlag
Patient Preference and Adherence;18:455-466.
Zum Eintrag

Building digital patient pathways for the management and treatment of multiple sclerosis

Link
https://doi.org/10.3389/fimmu.2024.1356436
Tags
Multiple SkleroseManagement & ScienceeHealth
Jahr
2024
Autoren
Wenk J, Voigt I, Inojosa H, Schlieter H and Ziemssen T.
Verlag
Front. Immunol. 15:1356436.
Zum Eintrag

Inhibitory Control in WM Gate-Opening: Insights from Alpha Desynchronization and Norepinephrine Activity Under atDCS Stimulation

Link
https://doi.org/10.1016/j.neuroimage.2024.120541
Tags
Andere
Jahr
2024
Autoren
Yu S, Konjusha A, Ziemssen T, Beste C.
Verlag
Neuroimage. 2024 Feb 13:120541. doi: 10.1016/j.neuroimage.2024.120541.
Zum Eintrag

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

Link
https://doi.org/10.1080/21645515.2024.2316422
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2024
Autoren
Ziemssen T, Groth M, Ettle B, Bopp T.
Verlag
Hum Vaccin Immunother. 2024 Dec 31;20(1):2316422.
Zum Eintrag

Understanding the Symptoms and Impacts Experienced by People with Relapsing-Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews

Link
https://doi.org/10.1007/s40120-024-00584-y
Tags
Multiple SkleroseMS Behandlung
Jahr
2024
Autoren
Barrett A, Olayinka-Amao O, Ziemssen T, Bharadia T, Henke C, Kamudoni P.
Verlag
Neurol Ther. 2024 Feb 12.
Zum Eintrag

Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance

Link
https://doi.org/10.1111/jsr.14164
Tags
NeuroimmunologieAndere
Jahr
2024
Autoren
Sehr T, Akgün K, Benkert P, Kuhle J, Ziemssen T, Brandt MD.
Verlag
J Sleep Res. 2024 Feb 13:e14164.
Zum Eintrag
4 5 6 7 8

Publikationen durchsuchen

Publikationen filtern

Filters
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Show AllHide
Jahr
-